KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

News
October 17, 2025
KHA President and CEO Nancy Galvagni testified before the Interim Joint Committee on Judiciary in support of legislation to address the problem of violent youth in Kentucky hospitals.
News
October 17, 2025
KHA held the annual Health Policy Conference on October 16 in Lexington.
News
October 14, 2025
The KHA team traveled to Hopkinsville on October 13 to present the KHA Legislative Champion Award to State Senator Craig Richardson.